EUVIMEDEUVIMED entdecken
Crossref

Feedback-Amplified Drug Delivery of αPD-L1-Modified Lipoplatin for Chronological Synergy in NSCLC through PD-L1 Upregulation

Yi Cen, Xin-Xuan Li, Ying Chen, Xiao-Cheng Ou, Bai-Xue Yu, Xia-Yun Chen, Yi-Bin Liu, Wen-Xiu Qiu iD, Xin Chen, You-Zhi Tang iD, Tao Wang, Ling-Wen Ding und 1 weitere

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c12335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Yi Cen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Fifth Affiliated Hospital, Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, NMPA and State Key Laboratory of Respirat…. Hauptthemen laut MEDLINE: Cisplatin, B7-H1 Antigen, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Medical Research Council, State Key Laboratory of Respiratory Disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinB7-H1 AntigenCarcinoma, Non-Small-Cell LungLung NeoplasmsAntineoplastic AgentsDrug Delivery SystemsHumansAnimalsMiceUp-RegulationCell Line, TumorLiposomesImmunotherapyMice, Inbred BALB CFemale

Stichwörter der Autor:innen

LipoplatinNSCLCfeedback-amplified tumor targetingimmune checkpoint blockade therapytumor-targeted drug delivery

Substanzen

CisplatinB7-H1 AntigenCD274 protein, humanlipoplatinAntineoplastic AgentsLiposomes

Autor:innen und Institutionen

  • Fifth Affiliated Hospital, Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical Univ…
  • Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, P. R. China.
  • Institute of Biology and Medicine, College of Life Science and Health, Wuhan University of Science and Technology, Wuhan 430081, P. R. China.
  • Department of Pulmonary and Critical Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, P. R. China.
  • State Key Laboratory of Respiratory Diseases, Guangdong Key Laboratory of Vascular Diseases, Guangzhou Institute of Respiratory Health, First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510120, P. R. Ch…
  • Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119074.

ORCID-Profile: Wen-Xiu Qiu, You-Zhi Tang, Shi-Ying Li

Förderung

  • National Key Research and Development Program of China
  • National Medical Research Council
  • State Key Laboratory of Respiratory Disease
  • National Research Foundation Singapore
  • Natural Science Foundation of Hubei Province
  • Hubei Provincial Department of Education
  • China Scholarship Council
  • National Natural Science Foundation of China

Zitieren

APA

Cen, Y., Li, X. X., Chen, Y., Ou, X. C., Yu, B. X., Chen, X. Y., Liu, Y. B., Qiu, W. X., Chen, X., Tang, Y. Z., Wang, T., Ding, L. W., & Li, S. Y. (2025). Feedback-Amplified Drug Delivery of αPD-L1-Modified Lipoplatin for Chronological Synergy in NSCLC through PD-L1 Upregulation. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c12335

Vancouver

Cen Y, Li XX, Chen Y, Ou XC, Yu BX, Chen XY, et al. Feedback-Amplified Drug Delivery of αPD-L1-Modified Lipoplatin for Chronological Synergy in NSCLC through PD-L1 Upregulation. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c12335

BibTeX
@article{Cen2025,
  author = {Cen, Yi and Li, Xin-Xuan and Chen, Ying and Ou, Xiao-Cheng and Yu, Bai-Xue and Chen, Xia-Yun and Liu, Yi-Bin and Qiu, Wen-Xiu and Chen, Xin and Tang, You-Zhi and Wang, Tao and Ding, Ling-Wen and Li, Shi-Ying},
  title = {Feedback-Amplified Drug Delivery of αPD-L1-Modified Lipoplatin for Chronological Synergy in NSCLC through PD-L1 Upregulation},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c12335}
}
Kostenlos starten →